Merck, Sharp & Dohme’s patent spat over Wyeth’s Prevnar 13 vaccine goes another round
Intellectual Property November 8, 2019 10:41 pm By Hannah Gee | Sydney

A case between drug company rivals Merck Sharp & Dohme and Wyeth over three patents for the Prevnar 13 pneumococcal vaccine has been reopened for […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.